Nuclein

Developer of handheld PCR device for the detection of infectious disease

placeAustin, Texas, United States calendar_todayFounded 2017 groups27 employees language nuclein.com

Innovation

6 patent families (2 granted) — focus: Operations & transport, Chemistry & metallurgy; filing pace steady. Cited 214 times.

YearFilings
20201
20212
20222
20234
20244
20252

Social engagement

Social engagement: 4.5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Trinity Investors.

Investor typeCountShare
Private equity1100%

Recent activity

30 Apr 2026
Expansion
market
22 Apr 2026
Event
UCA 2026
12 Apr 2026
Event
UCA 2026
Coming soon